Veterinary Infectious Disease Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Veterinary Infectious Disease Therapeutics Market is Segmented by Product Type (Antibiotics, Antiviral, Antifungal, Amebicides, and Others), Animal Type and Geography

Veterinary Infectious Disease Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Veterinary Infectious Disease Therapeutics Market Size

Veterinary Infectious Disease Therapeutics Market Size
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 5.80 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Veterinary Infectious Disease Therapeutics Market Key players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Veterinary Infectious Disease Therapeutics Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Veterinary Infectious Disease Therapeutics Market Analysis

The Veterinary Infectious Disease Therapeutics Market is expected to register a CAGR of 5.8% during the forecast period.

Microorganisms are tiny living creatures that are present everywhere, such as bacteria and viruses. Few of the thousands of species of microorganisms invade, multiply, and cause illness in animals and people. Most of the microorganisms live on the skin, in the mouth, upper airways and intestines without causing any harmful disease but some of the microorganism lives in or on a pet, or invades and causes disease depends on the nature of the microorganism and the state of the pet's natural defenses.

According to World Small Animal Veterinary Association (WSAVA), estimates that 60% to 80% of emerging diseases are zoonotic which indicates the importance of veterinarians in the identification, prevention, and control of infectious diseases. For Example, Rift Valley Fever is an endemic zoonotic disease in Africa and the Middle East that costs producers USD 427 million every year. Increasing prevalence of infectious disease and increasing demand for dairy, meat, and poultry products due to the increasing population size are the key driving factors in the veterinary infectious disease therapeutics market.

Veterinary Infectious Disease Therapeutics Industry Overview

The veterinary infectious disease therapeutics market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the major market players are Elanco, Merck & Co. Inc, Boehringer Ingelheim Vetmedica, Zoetis, Dechra Pharmaceuticals PLC, Ceva Sante, Virbac S.A, Bayer AG, Vetoquinol S.A, IDEXX Laboratories, Inc.

Veterinary Infectious Disease Therapeutics Market Leaders

  1. Elanco

  2. Merck & Co. Inc

  3. Boehringer Ingelheim Vetmedica

  4. Zoetis

  5. Dechra Pharmaceuticals PLC

  6. *Disclaimer: Major Players sorted in no particular order
Elanco. Merck & Co. Inc, Boehringer Ingelheim Vetmedica, Zoetis, Dechra Pharmaceutic
Need More Details on Market Players and Competiters?
Download PDF

Veterinary Infectious Disease Therapeutics Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Infectious Diseases in Animals
    • 4.2.2 Technological Advancements in Development of New Drugs
  • 4.3 Market Restraints
    • 4.3.1 Stringent Government Regulations
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Antibiotics
    • 5.1.2 Antiviral
    • 5.1.3 Antifungal
    • 5.1.4 Amebicides
    • 5.1.5 Others
  • 5.2 By Animal Type
    • 5.2.1 Dogs and Cats
    • 5.2.2 Horses
    • 5.2.3 Swine
    • 5.2.4 Poultry
    • 5.2.5 Other Animals
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Elanco
    • 6.1.2 Merck & Co. Inc
    • 6.1.3 Boehringer Ingelheim Vetmedica, Inc.
    • 6.1.4 Zoetis Inc.
    • 6.1.5 Dechra Pharmaceuticals PLC
    • 6.1.6 Ceva Santé Animale
    • 6.1.7 Virbac S.A
    • 6.1.8 Bayer AG
    • 6.1.9 Vetoquinol S.A
    • 6.1.10 IDEXX Laboratories, Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Veterinary Infectious Disease Therapeutics Industry Segmentation

As per the scope of the report, veterinary infectious diseases are the diseases that can get transmitted from one animal to another animal or into a human being. Despite their overwhelming abundance, relatively few of the hundreds of thousands of species of microorganisms invade, multiply, and cause illness in animals and people.

By Product Type Antibiotics
Antiviral
Antifungal
Amebicides
Others
By Animal Type Dogs and Cats
Horses
Swine
Poultry
Other Animals
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Veterinary Infectious Disease Therapeutics Market Research FAQs

What is the current Veterinary Infectious Disease Therapeutics Market size?

The Veterinary Infectious Disease Therapeutics Market is projected to register a CAGR of 5.8% during the forecast period (2025-2030)

Who are the key players in Veterinary Infectious Disease Therapeutics Market?

Elanco, Merck & Co. Inc, Boehringer Ingelheim Vetmedica, Zoetis and Dechra Pharmaceuticals PLC are the major companies operating in the Veterinary Infectious Disease Therapeutics Market.

Which is the fastest growing region in Veterinary Infectious Disease Therapeutics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Veterinary Infectious Disease Therapeutics Market?

In 2025, the North America accounts for the largest market share in Veterinary Infectious Disease Therapeutics Market.

What years does this Veterinary Infectious Disease Therapeutics Market cover?

The report covers the Veterinary Infectious Disease Therapeutics Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Veterinary Infectious Disease Therapeutics Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Veterinary Infectious Disease Therapeutics Industry Report

Statistics for the 2025 Veterinary Infectious Disease Therapeutics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Veterinary Infectious Disease Therapeutics analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Veterinary Infectious Disease Therapeutics Report Snapshots